Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Climate factors like UV index and rain can affect alopecia areata flares in children, especially those with allergies.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

The criteria help doctors diagnose and treat alopecia areata more effectively.

IMA and IMA/albumin levels don't predict alopecia areata severity.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Antioxidants can help improve hair growth in people with alopecia areata.

Prachanna followed by Chirabilwa lepa is more effective for alopecia areata than Prachanna followed by Gunja lepa.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Body structure can help identify alopecia areata in Ukrainian men, but not predict its course.

Both treatments are safe and effective, but anthralin may work better for some patients.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.